Functional properties of factor V and factor Va encoded by the R2-gene

Citation
L. Hoekema et al., Functional properties of factor V and factor Va encoded by the R2-gene, THROMB HAEM, 85(1), 2001, pp. 75-81
Citations number
48
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
THROMBOSIS AND HAEMOSTASIS
ISSN journal
03406245 → ACNP
Volume
85
Issue
1
Year of publication
2001
Pages
75 - 81
Database
ISI
SICI code
0340-6245(200101)85:1<75:FPOFVA>2.0.ZU;2-X
Abstract
Carriership of the factor V (FV) gene marked by the R2-haplotype, a series of linked polymorphisms encoding several amino acid changes in FV, is assoc iated with mild resistance to activated protein C (APC) and with an increas ed risk of thrombosis. We compared the functional properties of normal FV(a ) and R2-FV(a) in model systems and in plasma. FV and R2-FV were equally we ll activated by thrombin and expressed identical cofactor activities in pro thrombin activation. Rate constants of APC-catalyzed inactivation of FVa an d R2-FVa were similar both with and without protein S. However, significant differences were observed between haemostatic parameters determined in pla sma from homozygous carriers of the R2-gene (n = 5) and age-matched non-car riers (n = 19). Plasma from R2-carriers contained significantly lower FV le vels and the ratio of the two FV isoforms (FV1 and FV2) was shifted in favo r of FV1. The FV2/FV1 ratio was 1.4 (95% CI = 1.3-1.5) in homozygous carrie rs of R2 and 2.8 (95% CI = 2.5-3.1) in controls (p <0.00001). In an APC res istance test which quantifies the cofactor activity of FV in APC-catalyzed FVIII(a) inactivation, homozygous R2-carriers had significantly lower (p <0 .00001) APC sensitivity ratios (APCsr = 1.54, 95% CI = 1.48-1.60) than cont rols (APCsr = 2.17, 95% CI = 2.05-2.28). This indicates that R2-FV has redu ced cofactor activity in APC-catalyzed FVIII(a) inactivation. The changes o f the relative amounts of FV1 and FV2 in carriers of the R2-gene will resul t in increased thrombin formation in the presence of APC and may provide a mechanistic explanation for the increased thrombotic risk associated with t he R2-haplotype.